PCI Pharma Services ("PCI" or the "Company"), a world-leading global contract development and manufacturing organization ...

PCI Pharma Services has received a strategic investment co-led by Bain Capital and existing lead investor Kohlberg, and ...

More recently, PCI acquired a 100% stake in Ajinomoto’s fill-finish contracting arm Ajinomoto Althea. The deal, for which ...

A Philadelphia-based pharmaceutical services company has just received a massive investment from two major private equity firms, reportedly catapulting its valuation to $10 billion.

The CDMO, which has been owned by different private investors over the last decade, will use the funds to broaden its ...

The firms lead an investment valuing PCI Pharma at $10 billion, see the company benefiting from broader trends.

PCI Pharma Services, which is backed by Partners Group, Thomas H. Lee Partners and Frazier Healthcare, has acquired Bellwyck Pharma Services. Iris Dorbian - 11 February 2020 ...

PCI Pharma Services (PCI), a leading pharmaceutical and biopharmaceutical global supply chain solutions provider, today announced the acquisition of B ...

PCI Pharma Services, a Philadelphia contract drug manufacturer, is investing $50 million into a new manufacturing facility in Rockford that's expected to create about 250 jobs.

PCI Pharma Services began life as a drug packaging company before diversifying its business into the production of tablets, capsules, and semisolid and liquid oral preparations.

The auction of Frazier Healthcare Partners-backed PCI Pharma Services, which potentially valued the pharmaceutical outsourcing company at more than $1 billion, has attracted the interest of ...